Johnson & Johnson vs Motorola Solutions Inc — how do they compare? Johnson & Johnson trades at $261.44 (market cap $618.09B), while Motorola Solutions Inc trades at $444.18 (market cap $74.00B). The key difference: Johnson & Johnson is far larger — about 8.4× Motorola Solutions Inc's market cap, and Johnson & Johnson pays the higher dividend (2.09%). Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and Motorola Solutions Inc for 100 Days on average.
| JNJ | MSI | |
|---|---|---|
Market Cap | $618.09B | $74.00B |
Volume | 6,050,983 | 722,147 |
Sector | Health | Technology |
52-Week High | $278.43 | $491.24 |
52-Week Low | $186.00 | $363.83 |
Typical Hold Time | 129 Days | 100 Days |
Enterprise Value | $646.37B | $82.90B |
Dividend Yield | 2.09% | 1.08% |
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $256.48, down 0.76% on the day, with the stock showing mixed technical signals amid a bearish overall trend. The company maintains strong fundamentals with $94.19B in 2025 revenue, 21.48% net income margin, and consistent earnings beats in recent quarters. Recent analyst coverage shows 52.5% buy ratings with a $286.53 consensus price target, while technical indicators point to key support at $248 and resistance at $258.
JNJ presents a compelling long-term investment case with robust profitability, diversified healthcare portfolio, and dividend stability, though near-term headwinds include patent expirations and competitive pressures. The stock's current valuation at 29.75 P/E appears reasonable given strong cash flow generation and pipeline innovation, with upside potential to analyst targets if execution continues.
Motorola Solutions (MSI) trades at $447.12, down 0.3% with a bearish technical signal despite strong fundamentals. The company shows robust revenue growth from $11.68B in 2025 to $12.2B projected for 2026, with net income margins above 17%. Recent developments include a $1.5B D-Fend acquisition, a $61.3M US Navy contract, and a $2B share repurchase authorization. Analyst consensus remains strongly bullish with a $525.86 price target, though technical indicators show selling pressure near current levels.
MSI presents a compelling growth story with expanding defense contracts and strategic acquisitions driving revenue. However, elevated valuation ratios (P/E 35.23, P/S 6.14) and negative cash flow trends pose risks. The stock offers 17.6% upside to consensus target, but investors should monitor execution of recent acquisitions and cash flow improvement for sustained momentum.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.
Read more on MSI →